Evidence for Heterogenous Glycine Domains but Conserved Multiple States of the Excitatory Amino Acid Recognition Site of the NMDA Receptor: Regional Binding Studies with [3H]glycine and [3H]L-glutamate
Overview
Affiliations
The possible heterogeneity of the agonist and glycine sites of the N-methyl-D-aspartate (NMDA) receptor-complex was examined using receptor binding techniques. Binding of [3H]L-glutamate [( 3H]GLU) and [3H]glycine to synaptic membranes of cerebral and cerebellar cortices, and membranes of a granule cell preparation of rat cerebellum, was characterized. [3H]Glycine always labelled a single population of sites; densities of binding sites (Bmax) in cortical, cerebellar and "granule" membranes were 3.1, 0.87 and 3.6 pmol/mg protein, respectively. Dissociation constants (Kd) in the same three preparations were 0.13, 0.31 and 1.9 microM, respectively. In competition studies, D-cycloserine, but not D-serine and 7-chlorokynurenate, showed varying potency between the membrane preparations, and analysis of variance (ANOVA) revealed a significant interaction between ligands and membrane fractions. Binding of [3H]GLU was saturable and to a single population of sites: Kd 0.5-0.9 microM and Bmax 3.2-3.6 pmol/mg protein. In all three membrane preparations the rank order of potency of NMDA agonists as inhibitors of the binding of [3H]GLU was always L-aspartate greater than L-cysteate greater than L-cysteinesulphinate greater than L-serine-O-sulphate greater than ibotenate greater than L-homocysteate. NMDA, quinolinate and competitive NMDA antagonists were only weak inhibitors of the binding of [3H]GLU and never fully inhibited specific binding. Other subtype-selective excitatory amino acids were very weak or ineffective inhibitors of binding. Binding of NMDA agonists was better described by a two site model whereby the proportion of high affinity sites did not vary significantly across the three membrane preparations.(ABSTRACT TRUNCATED AT 250 WORDS)
Does kynurenic acid act on nicotinic receptors? An assessment of the evidence.
Stone T J Neurochem. 2019; 152(6):627-649.
PMID: 31693759 PMC: 7078985. DOI: 10.1111/jnc.14907.
The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries.
Lodge D, Watkins J, Bortolotto Z, Jane D, Volianskis A Neurochem Res. 2018; 44(3):516-530.
PMID: 30284673 PMC: 6420420. DOI: 10.1007/s11064-018-2640-6.
The kynurenine pathway and the brain: Challenges, controversies and promises.
Schwarcz R, Stone T Neuropharmacology. 2016; 112(Pt B):237-247.
PMID: 27511838 PMC: 5803785. DOI: 10.1016/j.neuropharm.2016.08.003.
Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain.
DSouza S, McConnell S, Slater P, BARSON A Arch Dis Child. 1993; 69(2):212-5.
PMID: 8215523 PMC: 1029459. DOI: 10.1136/adc.69.2.212.
Carroll C, Holloway V, Brotchie J, Mitchell I Psychopharmacology (Berl). 1995; 119(1):55-65.
PMID: 7675950 DOI: 10.1007/BF02246054.